| 标题 |
Abstract P5-15-11: Eribulin should be a candidate strategy in combination with pertuzumab plus trastuzumab for taxane pretreated HER2 positive advance breast cancer |
| 网址 | |
| DOI |
10.1158/1538-7445.sabcs16-p5-15-11
doi
|
| 其它 |
期刊:Cancer Research 作者:K Araki; I Fukada; K Kobayashi; S Takahashi; Y Ito 出版日期:2017-02-15 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)